Matthew Pittappilly

Internal Medicine physician in New Orleans, Louisiana — also lists obesity medicine in the CMS registry.

Practice Details

Address
131 S Robertson St # 8045
New Orleans, LA 70112
Geocoded location: 29.9581, -90.0772
Taxonomy
Surgery
Credential
MD
NPPES Enumeration
Listed with NPPES since 2017
Sole Proprietor
No
Provider Gender (NPPES)
Male
NPPES Record Updated
August 2024

Specialty taxonomies on file (2)

  • Bariatric Surgery
    Surgery
  • Internal Medicine
    Internal Medicine, Nephrology
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Matthew Pittappilly is an Internal Medicine physician in New Orleans whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 134 Surgery practices in New Orleans carrying this exact taxonomy in our directory.

What to expect at an Internal Medicine visit

Internal-medicine practices manage adult and often complex chronic conditions. A GLP-1-related visit commonly involves:

  • A review of chronic conditions, medications, and cardiovascular/metabolic risk.
  • Baseline labs (A1c, metabolic panel, lipids) to guide treatment.
  • A discussion of GLP-1 options for diabetes and/or weight management.
  • A plan for follow-up monitoring and dose adjustment.

This is general guidance for internal medicine practices, not a description of Matthew Pittappilly's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 504-988-7518.

GLP-1 access in New Orleans, Louisiana

Adult obesity rate
38.6%
#5 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$195/mo
Typical Louisiana telehealth cash price
Medicaid GLP-1 coverage
Diabetes only
Louisiana Medicaid, obesity indication

About 38.6% of Louisiana adults have obesity (BMI 30+), ranking the state #5 of 50 (CDC BRFSS). Our directory currently lists 51 GLP-1-relevant clinics in New Orleans. If a cash-pay route makes more sense, compounded semaglutide through Louisiana telehealth averages about $195/mo — well below brand-name Wegovy or Zepbound.

Explore more Louisiana options on the best Louisiana GLP-1 providers page, browse every New Orleans listing in the New Orleans clinic directory, or read the Louisiana Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in New Orleans

Other New Orleans listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Louisiana addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Louisiana telehealth partners:

Featured Partners · New Orleans

Featured GLP-1 providers serving New Orleans

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $179/mo

    Save $1,170/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $146/mo

    Save $1,203/mo vs Wegovy
    Get started →
  4. Compounded from

    $215.67/mo

    Save $870.33/mo vs Zepbound
    Get started →
  5. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  6. Compounded from

    $179/mo

    Save $1,170/mo vs Wegovy
    Get started →

See more New Orleans options on the New Orleans clinic directory, our New Orleans GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by New Orleans obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Matthew Pittappilly's specialty taxonomy but not the specific medications it prescribes or its current service menu. Matthew Pittappilly is listed under Internal Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 504-988-7518 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Matthew Pittappilly's primary specialty on file is Internal Medicine, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Matthew Pittappilly is located at 131 S Robertson St # 8045, New Orleans, LA 70112. The phone number listed in the registry is 504-988-7518. Its full record is public in the CMS National Provider registry under NPI 1518497460.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Matthew Pittappilly is currently accepting new patients. Call the practice at 504-988-7518 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.